We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGusbourne Regulatory News (GUS)

Share Price Information for Gusbourne (GUS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 59.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.172%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 59.50
GUS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed fundraise

12 Jul 2018 10:40

RNS Number : 4579U
Gusbourne PLC
12 July 2018
 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

12 July 2018

Gusbourne Plc

 ("Gusbourne", the "Company" or the "Group")

Proposed fundraise

Gusbourne (London-AIM: GUS), announces its intention to raise between £3 million and £5 million, by way of an offer for subscription for new ordinary shares ("New Shares") at a subscription price of 60 pence per ordinary share (the "Subscription").

The Company also intends to issue share warrants ("Warrants") to subscribers of New Shares on a one for one basis, giving them the right to subscribe for ordinary shares in the Company ("Shares") at an exercise price of 60 pence per Share, the exercise of all of which would raise a further amount of up to £5.0 million by no later than 30 September 2019.

The subscription price of 60 pence represents a discount of approximately 11 per cent to the Company's closing share price as at 11 July 2018, being the latest practicable date prior to this announcement.

An explanatory letter and application form are being sent to selected shareholders and other offerees providing further detail on the Subscription and the application process. The Company expects to close the Subscription by 17 August 2018, following which it will announce the final amount raised. The Company may at its discretion extend this deadline but, in any event, to no later than 31 August 2018.

The Subscription is being made available to a limited selection of shareholders and other offerees, in order to avoid the requirement to publish a Prospectus in accordance with section (86)(1)(b) of the Financial Services and Markets Act 2000. Such action has been taken to avoid substantial costs for the Company and the requirement for significant management resource in the short to mid-term, that the directors believe would be a hindrance to implementing Gusbourne's strategy.

Summary of the New Shares and the Warrants

The New Shares will rank pari passu with the Company's existing ordinary shares and will be issued at a price of 60 pence per ordinary share. If £5.0 million is raised by the issue of New Shares, the New Shares would represent 17.5% of the Company's then enlarged issued share capital.

The main features of the Warrants are:

· Warrants will be issued to holders of New Shares as to one Warrant for every one New Share for which the subscriber subscribes.

· Warrants will be exercisable, in whole or in part, by the holder giving notice. in the prescribed format to the Company, accompanied by the remittance of the subscription monies in respect of such exercise. The latest date for exercise of the Warrants and remittance of the subscription monies is 30 September 2019.

· Each Warrant will, upon exercise, entitle the holder to exchange one Warrant for one Share at an exercise price of 60 pence per Share.

· Any increased yield provided by the Warrants would depend on the market value of the Shares at the time of exercise and a subsequent sale.

· Not transferable and not traded on any stock exchange.

The exercise of the Warrants will always be conditional on the power of the Company's directors to allot the relevant number of Shares and to do so free from pre-emption rights. The level of such power given to the Company's directors by the Company's shareholders at the Company's Annual General Meetings to date comfortably exceeds the level required to allot all Shares which could fall for allotment pursuant to the exercise of Warrants.

A copy of the Warrant Instrument can be provided by the Company to potential subscribers upon request.

Use of proceeds

The net proceeds from this fundraising will be used for capital expenditure on the Company's existing vineyards until maturity, additional winery and storage capacity and working capital, particularly with regard to the Company's increasing wine stocks.

Intentions of directors regarding fundraise

The following Directors of the Company have indicated their intentions to apply for New Shares in at least the following amounts:

Mike Paul, £50,000

Lord Arbuthnot, £15,000

Ian Robinson, £25,000

Intentions of Lord Ashcroft KCMG PC regarding fundraise and loan repayment

Lord Ashcroft KCMG PC, who currently holds approximately 72.4% of Gusbourne's issued share capital, has indicated his intent to apply for New Shares by grossing up the amount raised from other subscribers such that his application will be for an amount of up to 72.4% of the total amount raised. By way of illustration, if the amount raised from other subscribers is £1.38 million Lord Ashcroft would intend to apply for up to £3.62 million, providing a total amount raised of £5.0 million. Depending on the amount raised from other subscribers, Lord Ashcroft may, at his sole discretion, gross up by an amount less than the 72.4% noted above. Furthermore, the Company may, at its sole discretion, scale back applications from other subscribers if they exceed £1.38 million.

Lord Ashcroft would make some or all of his subscription by converting into New Shares the relevant proportion of the capital of, and accrued interest on, a loan of £1.0 million which he made to the Company on 31 May 2018. Since the Company's announcement of his making of that loan, he has varied the terms such that his right to convert has been deferred from 31 July 2018 until 31 August 2018.

 

Enquiries:

Gusbourne Plc

Charlie Holland +44 (0)1233 758 666

Cenkos Securities plc

Nicholas Wells / Callum Davidson +44 (0)20 7397 8920

 

Note: This announcement and other press releases are available to view at the Company's website: www.gusbourneplc.com

 

This announcement is addressed only to and directed only at: (a) persons in the United Kingdom who are 'Qualified Investors' falling within the meaning of article 2(1)(e) of the Prospectus Directive (which means Directive 2003/71/EC and includes any relevant implementing directive measure in the UK) who (i) have professional experience in matters relating to investments falling within article 19(5) ("Investment professionals") of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order"); or (ii) fall within article 49(2)(a) to (d) ("High net worth companies, unincorporated associations, etc") of the Order; or (b) persons to whom it may otherwise be lawfully communicated (all such persons in contemplated in (a) or (b) together being referred to as "Relevant Persons"). This announcement must not be acted on or relied on by persons who are not Relevant Persons. Any investment or investment activity to which this announcement or the Placing relates is available only to and will be engaged in only with Relevant Persons.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFKBDNCBKKFOD
Date   Source Headline
31st Jan 20247:00 amRNSTrading Statement
19th Jan 20244:20 pmRNSRefinancing of existing loan facilities
17th Jan 20247:00 amRNSBoard Changes and CEO Designate Appointment
4th Jan 202412:26 pmRNSIssue of Equity
21st Dec 20237:00 amRNSAuditor Change
30th Nov 20237:00 amRNSDirectorate Change
14th Nov 20237:00 amRNSShort term Unsecured Loan & Extension of Warrants
3rd Nov 20233:00 pmRNSIssue of Equity
26th Oct 20237:00 amRNSWarrant Exercise/PDMR Dealings
19th Oct 20237:00 amRNSHarvest Report
28th Sep 20237:00 amRNSInterim results to 30 June 2023
6th Sep 20237:00 amRNSBoard Change and Appointment of Interim CEO
1st Sep 20237:00 amRNSIssue of Equity
29th Jun 20232:42 pmRNSResult of AGM
27th Jun 20237:00 amRNSBoard Change
7th Jun 20237:00 amRNSFinal Results
21st Mar 20237:00 amRNSDirectorate Change
14th Feb 202312:12 pmRNSAIM Rule 17 Notification
31st Jan 20237:00 amRNSTrading Update
16th Jan 20231:32 pmRNSIssue of Equity
20th Dec 20227:00 amRNSGrant of Share Options
16th Dec 202210:30 amRNSIssue of Equity
14th Dec 20227:00 amRNSExtension of the final exercise date of Warrants
27th Oct 20227:00 amRNSHarvest Report
4th Oct 20221:51 pmRNSIssue of Equity
29th Sep 20227:00 amRNSInterim results to 30 June 2022
6th Sep 20227:00 amRNSChange of Adviser
22nd Aug 20227:00 amRNSDirectorate Change
15th Aug 20227:00 amRNSTrading Update, Refinancing & Land Purchase
30th Jun 20222:00 pmRNSResult of AGM
6th Jun 20227:00 amRNSFinal Results
3rd May 202210:15 amRNSIssue of Equity
29th Mar 202212:10 pmRNSIssue of Equity
2nd Mar 20229:30 amRNSIssue of Equity
10th Feb 20227:00 amRNSTrading Update
17th Dec 20217:00 amRNSCompletion of Warrant Issue
15th Dec 20213:50 pmRNSFurther re Issue of Warrants
15th Dec 20217:00 amRNSResult of Open Offer and Issue of Warrants
22nd Nov 20217:00 amRNSLaunch of Open Offer and Posting of Circular
2nd Nov 20214:34 pmRNSDirector/PDMR Shareholding
1st Nov 20217:00 amRNSResult of Warrant Exercise and Debt Conversion
18th Oct 20214:30 pmRNSApplication for Admission
18th Oct 20212:10 pmRNSResult of ABB
18th Oct 20217:01 amRNSPlacing and Subscription
18th Oct 20217:00 amRNSFunding Update
30th Sep 20217:00 amRNSInterim Results to 30 June 2021
10th Aug 20217:38 amRNSIssue of Equity
23rd Jul 20217:00 amRNSDirector/PDMR Shareholding
22nd Jul 20217:00 amRNSTrading and Capital Structure Update
19th Jul 20211:00 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.